Experience with cyclosporine in pediatric renal transplantation

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S211-S215

  Willetts, I E ^a   Trompeter, R S ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MERCAPTOPURINE; METHYLPREDNISOLONE; PREDNISONE;

ACNE; ASEPTIC NECROSIS; CLINICAL PROTOCOL; CLINICAL TRIAL; DIALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG MONITORING; EXPERIENCE; EXPERIMENTAL MODEL; GINGIVA HYPERPLASIA; GRAFT REJECTION; GRAFT SURVIVAL; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MYOPATHY; NEPHROTOXICITY; NONHUMAN; OSTEOPOROSIS; PATIENT COMPLIANCE; PEDIATRICS; PEPTIC ULCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSYCHOSIS; REACTION OPTIMIZATION; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 1642339648     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.01.047     Document Type: Article

References (48)

1. Hamburger J. Memories of old times. Terasaki P. History of Transplantation: Thirty-five Recollections. 1991;63 UCLA Tissue Typing Laboratory, Los Angeles, Calif.
2. Michon L., Hamburger J., Oeconomos N. Une tentative de transplantation renale chez d'homme. Presse Med. 61:1953;1419.
3. Schwartz R., Dameshek W. Drug-induced immunological tolerance. Nature. 183:1959;1682.
4. Calne R. The inhibition of renal homograft rejection in dogs by 6-mercaptopurine. Lancet. i:1960;417.
5. Kuss R., Legraine M., Mathe G., et al. Homologous human kidney transplantation. Postgraduate Medical Journal. 38:1962;528.
6. Starzl T., Marchioro T., Waddell W. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surgery Gynecology Obstetrics. 117:1963;385.
7. Hume D. Annals Surgery. 158:1963;608.
8. Starzl T, Schroter G, Hartmann N, et al: Long-term survival after renal homotransplantation - the world experience. Transplant Proc 1990
9. Najarian J., Frey D., Matas A., et al. Renal transplantation in infants. Ann Surg. 212:1990;353.
10. Opelz G., Sengar D., Mickey M., et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 5:1973;253.
11. Kahan B., Van Buren C., Flechner S. Cyclosporine immunosuppression mitigates immunologic risk factors in renal allotransplantation. Transplant Proc. 15:1983;2469.
12. Sutherland D., Fryd D., So S. Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Transplantation. 38:1984;619.
13. Trompeter R., Bewick M., Haycock G., et al. Renal transplantation in very young children. Lancet. i:1983;373.
14. Trompeter R. Renal transplantation in children. British Journal Hospital Medicine. 44:1990;279.
15. Calne R., Rolles K., White D. Cyclosporin A initially as the only immunosuppressant in 36 recipients of cadaveric organs 32 kidneys, 2 pancreas and 2 livers. Lancet. ii:1979;1033.
16. Opelz G. Multicentre impact of cyclosporin on kidney cadaver graft survival. Prog Allergy. 38:1986;329.
17. Morris P., Russell C. Cyclosporine. Morris P. Kidney Transplantation: Principles and Practice. 2001;227 WB Saunders, London.
18. Benfield M., McDonald R., Bartosh S., et al. Changing trends in pediatric transplantation Annual report on the NAPRTCS. Pediatric Transplantation. 7:2003;321.
19. Fine R., Edelbrock H., Riddell H., et al. Renal transplantation in children. Urology. 9:1977;61.
20. Trompeter R., Filler G., Webb N., et al. Randomised trial of tacrolimus versus cyclosporin microimmulsion in renal transplantation. Pediatric Nephrology. 17:2002;141.
21. Matas A., Gillingham K., Payne W., et al. The impact of an acute rejection episode on long-term renal allograft survival. Transplantation. 57:1994;857.
22. Kahan B., et al. Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporin. Transplant Proc. 18:1986;115.
23. Neiberger R., Weiss R., Gomez M., et al. Elimination kinetics of cyclosporin following oral administration to children with renal transplants. Transplant Proc. 19:1987;1525.
24. Hoppu K., Koskimies O., Holmberg C., et al. Pharmacokinetically determined cyclosporine dosage in young children. Pediatric Nephrology. 5:1991;1.
25. Ettenger R., Rosenthal J., Marik J., et al. Cadaver renal transplantation in children results with long-term cyclosporin immunosuppression. Clinical Transplantation. 4:1990;329.
26. Cooney G., Habucky K., Hoppu K. Cyclosporin pharmacokinetics in paediatric transplant recipients. Clin Pharmacokinet. 32:1997;481.
27. Mahalati K., Belitsky P., West K., et al. Approaching the therapeutic window for cyclosporine in kidney transplantation a prospective study. J Am Soc Nephrol. 12:2001;828.
28. Trompeter R., Fitzpatrick M., Hutchinson C., et al. Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption. Pediatric Transplantation. 7:2003;282.
29. Alexoupoulos E., Leontsini M., Daniilidis M., et al. Differentiation between renal allograft rejection and CsA toxicity a clinicopathological study. Am J Kidney Dis. 18:1991;108.
30. Myers B., Newton L., Oyer P. The case against theindefinite use of cyclosporine. Transplant Proc. 23:1991;41.
31. Hong J., Sumrani N., Delaney V., et al. Causes of late renal allograft failure in the cyclosporin era. Nephron. 62:1992;272.
32. Buturovic J., Kandus A., Malovrh M., et al. Cyclosporin associated haemolytic uraemic syndrome in four renal allograft recipients resolution without specific therapy. Transplant Proc. 22:1990;1726.
33. Hoyer P., Offner G., Oemar B., et al. Four years experience with cyclosporine in paediatric kidney transplantation. Acta Pediatr Scand. 79:1990;622.
34. DeCamargo P. Cyclosporin- and nifedipine-induced gingival enlargement an overview. J West Soc Periodontol. 37:1989;57.
35. Crocker J., Dempsey T., Schenk M., et al. Cyclosporin A toxicity in children. Transplant Reviews. 7:1993;72.
36. Morel P., Almond P., Matas A., et al. Long-term quality of life after kidney transplantation in childhood. Transplantation. 52:1991;47.
37. Manificat S., Dazord A., Cochat P., et al. Quality of life of children and adolescents after kidney or liver transplantation child, parents and caregiver's point of view. Pediatric Transplantation. 7:2003;228.
38. Colon E., Popkin M., Matas A., et al. Overview of non-compliance in renal transplantation. Transplant Reviews. 5:1991;175.
39. Almond P., Matas A., Gillingham K., et al. Pediatric renal transplants results with sequential immunosuppression. Transplantation. 53:1992;46.
40. Tejani A., Sullivan E., Alexander S., et al. The impact of donor source, recipient age, pre-operative immunotherapy and induction therapy on early and late rejections in children a report of the NAPRTCS. Pediatric Transplantation. 2:1998;318.
41. McDonald R., Emmett L., Tejani A. Living donor transplantation in North American children the 1998 annual NAPRTCS report. Pediatric Transplantation. 4:2000;221.
42. So S., Gillingham K., Cook M., et al. The use of cadaver kidneys for transplantation in young children. Transplantation. 50:1990;979.
43. Najarian J., Ferguson R., Sutherland D., et al. A prospective trial of the efficacy of cyclosporine A in renal transplantation at the University of Minnesota. Transplant Proceedings. 15:1983;438.
44. Tejani A., Stablein D., Fine R., et al. Maintenance immunosuppresion therapy and outcome of renal transplantation in North American children a report of NAPRTCS. Pediatric Nephrology. 7:1993;132.
45. Kaiser B., Polinsky M., Palmer J., et al. Growth after conversion to alternate day corticosteroid in children with renal transplants a single-centre study. Pediatric Nephrology. 8:1994;320.
46. Dharnidharka V., Stablein D., Tejani A., et al. Risk factors for post transplant lymphoproliferative disorder in paediatric kidney transplantation a NAPRTCS report. Transplantation. 71:2001;1065.
47. Filler G., Trompeter R., Webb N., et al. One-year GFR predicts graft survival in paediatric renal recipients a randomised trial of tacrolimus vs. CsA microemulsion. Transplant Proc. 43:2002;1935.
48. Kahan B. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction. Transplantation. 71:2001;52.